Cite
Gudeman J, Jozwiakowski M, Chollet J, et al. Potential risks of pharmacy compounding. Drugs R D. 2013;13(1):1-8doi: 10.1007/s40268-013-0005-9.
Gudeman, J., Jozwiakowski, M., Chollet, J., & Randell, M. (2013). Potential risks of pharmacy compounding. Drugs in R&D, 13(1), 1-8. https://doi.org/10.1007/s40268-013-0005-9
Gudeman, Jennifer, et al. "Potential risks of pharmacy compounding." Drugs in R&D vol. 13,1 (2013): 1-8. doi: https://doi.org/10.1007/s40268-013-0005-9
Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D. 2013 Mar;13(1):1-8. doi: 10.1007/s40268-013-0005-9. PMID: 23526368; PMCID: PMC3627035.
Copy
Download .nbib